Update on Alzheimer's disease: recent findings and treatments.
作者信息
O'Hara R, Mumenthaler M S, Yesavage J A
机构信息
Department of Psychiatry and Behavioral Sciences, Stanford University, CA 94305-5550, USA.
出版信息
West J Med. 2000 Feb;172(2):115-20. doi: 10.1136/ewjm.172.2.115.
Abstract
摘要
相似文献
1
Update on Alzheimer's disease: recent findings and treatments.阿尔茨海默病最新进展：近期研究成果与治疗方法
West J Med. 2000 Feb;172(2):115-20. doi: 10.1136/ewjm.172.2.115.
2
Donepezil (Aricept) therapy for Alzheimer's disease.多奈哌齐（安理申）用于治疗阿尔茨海默病。
Compr Ther. 1997 Jul;23(7):492-3.
3
Alzheimer's disease: the advent of effective therapy.阿尔茨海默病：有效治疗方法的出现。
Aust N Z J Med. 1998 Dec;28(6):765-71. doi: 10.1111/j.1445-5994.1998.tb01551.x.
4
From mechanisms to drugs in Alzheimer's disease.从阿尔茨海默病的发病机制到药物研发
Lancet. 1997 Feb 15;349(9050):480. doi: 10.1016/s0140-6736(05)61198-1.
5
[Drugs for the treatment of Alzheimer's disease].
Nihon Rinsho. 2004 Jan;62 Suppl:76-80.
6
Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.抗胆碱酯酶药物在阿尔茨海默病中的应用：对中度严重疾病有一定疗效。
Prescrire Int. 2003 Dec;12(68):230-1.
7
[Treatment of the elderly dementia patients].[老年痴呆症患者的治疗]
Nihon Ronen Igakkai Zasshi. 2000 Nov;37(11):879-81.
8
Alzheimer's disease management.阿尔茨海默病的管理
J Clin Psychiatry. 1998;59 Suppl 13:4-5.
9
New drugs for Alzheimer's disease in Japan.日本治疗阿尔茨海默病的新药
Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x.
10
Use of cholinesterase inhibitors for treatment of Alzheimer disease.使用胆碱酯酶抑制剂治疗阿尔茨海默病。
Cleve Clin J Med. 2001 Jul;68(7):608-9, 613-4, 616. doi: 10.3949/ccjm.68.7.608.
引用本文的文献
1
The Effect of Tacrine on Functional Response of the Lower Oesophageal Sphincter Assessed by Endoscopic Luminal Impedance Planimetry in Experimental Pigs.他克林对实验猪食管下括约肌功能反应的影响：通过内镜腔内阻抗平面测量法评估
Pharmaceuticals (Basel). 2024 Nov 25;17(12):1588. doi: 10.3390/ph17121588.
2
A Systematic Review of Nonpharmacological Interventions for Moderate to Severe Dementia: A Study Protocol for a Systematic Review and Meta-Analysis.中度至重度痴呆非药物干预的系统评价：一项系统评价与荟萃分析的研究方案
Psychiatry Investig. 2018 Apr;15(4):417-423. doi: 10.30773/pi.2017.09.06. Epub 2018 Mar 26.
3
Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.综合心理刺激方案对阿尔茨海默病患者的有益影响。
J Alzheimers Dis. 2016;50(2):559-66. doi: 10.3233/JAD-150455.
4
Development of the ubiquitous spaced retrieval-based memory advancement and rehabilitation training program.普及的基于间隔检索的记忆增强和康复训练方案的研发。
Psychiatry Investig. 2014 Jan;11(1):52-8. doi: 10.4306/pi.2014.11.1.52. Epub 2014 Jan 21.
本文引用的文献
1
Donepezil for mild and moderate Alzheimer's disease.多奈哌齐用于治疗轻度和中度阿尔茨海默病。
Cochrane Database Syst Rev. 2000(4):CD001190. doi: 10.1002/14651858.CD001190.
2
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.利培酮、安慰剂和氟哌啶醇治疗痴呆行为症状的随机试验。
Neurology. 1999 Sep 22;53(5):946-55. doi: 10.1212/wnl.53.5.946.
3
Social disengagement and incident cognitive decline in community-dwelling elderly persons.社区居住老年人的社交脱离与认知能力下降
Ann Intern Med. 1999 Aug 3;131(3):165-73. doi: 10.7326/0003-4819-131-3-199908030-00002.
4
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.用β-淀粉样蛋白免疫可减轻PDAPP小鼠的阿尔茨海默病样病理变化。
Nature. 1999 Jul 8;400(6740):173-7. doi: 10.1038/22124.
5
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.APOE ε4在调节老年人认知功能衰退其他风险因素的作用方面。
JAMA. 1999 Jul 7;282(1):40-6. doi: 10.1001/jama.282.1.40.
6
Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.绝经后阿尔茨海默病女性经皮雌激素治疗的认知和神经内分泌反应：一项安慰剂对照、双盲、试点研究的结果
Psychoneuroendocrinology. 1999 Aug;24(6):657-77. doi: 10.1016/s0306-4530(99)00020-7.
7
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.胆碱酯酶抑制剂：一种治疗阿尔茨海默病的策略。
Ann Pharmacother. 1999 Apr;33(4):441-50. doi: 10.1345/aph.18211.
8
The effects of donepezil in Alzheimer's disease - results from a multinational trial.多奈哌齐治疗阿尔茨海默病的效果——一项跨国试验的结果
Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):237-44. doi: 10.1159/000017126.
9
Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.载脂蛋白E4、胆碱能完整性与阿尔茨海默病的药物遗传学
J Psychiatry Neurosci. 1999 Mar;24(2):147-53.
10
Mild cognitive impairment: clinical characterization and outcome.轻度认知障碍：临床特征与转归
Arch Neurol. 1999 Mar;56(3):303-8. doi: 10.1001/archneur.56.3.303.
Zotero 插件